# A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma

> **NCT02939807** · PHASE2 · WITHDRAWN · sponsor: **Medical University of South Carolina**

## Conditions studied

- Carcinoma, Hepatocellular

## Interventions

- **DRUG:** ABC294640

## Key facts

- **NCT ID:** NCT02939807
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-09-30
- **Primary completion:** 2023-09-30
- **Final completion:** 2024-01-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** study is being rewritten for different disease population
- **Last updated:** 2025-04-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02939807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02939807, "A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02939807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*